Rafael Franco-cendejas - Infectious Diseases

Author Information

Rafael Franco-Cendejas is affiliated with the Infectious Diseases Division at the Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", located at Calz. México-Xochimilco No. 289, Col. Arenal de Guadalupe, Ciudad de México 14389, Mexico. His work is primarily focused on infectious diseases, and he is actively involved in research that spans various aspects of this field.

Research Contributions

Rafael Franco-Cendejas has made significant contributions to the field of infectious diseases through his research on topics such as COVID-19, drug resistance, and sepsis. His recent work includes studies on the genetic variants associated with severe outcomes of COVID-19, the prevalence of SARS-CoV-2 infection among healthcare workers, and the investigation of drug resistance phenotypes in Mexico. He has also explored the clinical significance of Staphylococcus epidermidis in prosthetic joint infections, and the potential for vertical transmission of SARS-CoV-2.

Aliases

Rafael Franco-Cendejas is also known by aliases such as R. Franco-Cendejas and R. Franco–cendejas. These variations may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	426
H-index	12
Total Paper Count	61

Publications:

ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men

DOI: 10.3389/fimmu.2022.812940

Year: 2022

Synovial fluid analysis for the enhanced clinical diagnosis of crystal arthropathies in a tertiary care institution

DOI: 10.1007/s10067-021-05610-0

Year: 2021

Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network

DOI: 10.1371/journal.pone.0248614

Year: 2021

Staphylococcus epidermidis small colony variants, clinically significant quiescent threats for patients with prosthetic joint infection.

DOI: 10.1016/j.micinf.2021.104854

Year: 2021

Ocular surface characteristics and colonization in a burn center: A prospective cohort study.

DOI: 10.1093/jbcr/irab040

Year: 2021

Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a “non-COVID” hospital in Mexico City

DOI: 10.1371/journal.pone.0255916

Year: 2021

Probable Case of Vertical Transmission of SARS-CoV-2 in a Newborn in Mexico

DOI: 10.1159/000514710

Year: 2021

649. Evaluation of the NG-Test CARBA 5® in Enterobacteriaceae and P. aeruginosa from Clinical Isolates

DOI: 10.1093/ofid/ofab466.846

Year: 2021

Association of TLR4 gene polymorphisms with sepsis after a burn injury: findings of the functional role of rs2737190 SNP

DOI: 10.1038/s41435-021-00121-z

Year: 2021

236. Insight of Polymicrobial Prosthetic Joint Infections at a Referral Hospital

DOI: 10.1093/ofid/ofab466.438

Year: 2021

Can Glycolysis Be a Therapeutic Target?

How Do Immunodeficiency Disorders Affect Susceptibility to Infections?

What is the Current Research Focus?

What Are Some Common Diseases Spread by Direct Contact?

What are the Symptoms?

Why Are Cohort Studies Important?

What are Natural Killer (NK) Cells?

What are the Symptoms of Rabies?

What are the Criteria for Eradication?

What is MMR?

Partnered Content Networks

Relevant Topics